Aspire Biopharma Holdings, Inc. Common Stock logo

Aspire Biopharma Holdings, Inc. Common Stock

ASBP • NASDAQ

Aspire Biopharma Holdings, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Kraig T. Higginson, with a market cap of $4.6M.

CEOKraig T. Higginson
Market Cap$4.6M
PHARMACEUTICAL PREPARATIONS
Websiteaspirebiolabs.com

Next Earnings

Upcoming earnings announcement for Aspire Biopharma Holdings, Inc. Common Stock

Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026

Earnings History

Past 4 earnings reports for Aspire Biopharma Holdings, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Apr 8, 2026Q4 2025
-$1.84
—
$4.3K
—SEC10-K/A
Nov 14, 2025Q3 2025
-$0.04
—
$1.9K
—SEC10-Q
Aug 13, 2025Q2 2025
-$0.04
—
-
—SEC10-Q/A
May 14, 2025Q1 2025
-$0.42
—
-
—SEC10-Q
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Q1 2026 Earnings - Capbase